No profile data available.
Thermo Fisher Scientific Inc. (TMO) is a healthcare company in the standard laboratory equipment industry, based in Waltham, United States, with about 125,000 full-time employees.
It reported revenue of $44.56 billion for fiscal year 2025, up 3.9% from fiscal year 2024, and net income of $6.70 billion. In Q2 2026 (the quarter ended June 30, 2026) revenue was $11.99 billion, up 10.5% from a year before. Its largest business segment, Laboratory Products and Biopharma Services, brought in 51% of segment revenue in fiscal year 2025; Other Regions was the largest region with 50%. Its market capitalization was $243.30 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services.
Thermo Fisher Scientific reported $44.56 billion in revenue for fiscal year 2025, up 3.9% from $42.88 billion in fiscal year 2024. In Q2 2026 revenue was $11.99 billion.
Laboratory Products and Biopharma Services, with $23.98 billion or 51% of segment revenue in fiscal year 2025. Next: Life Sciences Solutions (22%) and Analytical Instruments (16%).
Other Regions: 50% of revenue by region in fiscal year 2025, followed by United States (50%).
$243.30 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (standard laboratory equipment) include Waters Corporation (WAT), Steris plc (STE), 908 Devices Inc. (MASS), Scientific Industries, Inc. (SCND).